Keith Alcorn

Keith joined NAM’s staff team in 1991 and was our Senior Editor until 2018. He currently contributes news and conference reporting to aidsmap.com and edits infohep.org, our website covering hepatitis treatment news.

Drug-resistant TB

Shorter, less toxic treatment for highly drug-resistant TB cures nine out of ten

Viral load

Viral suppression in Uganda improved by more viral load tests, done faster

Coronavirus

Lower CD4 count and unsuppressed HIV raise the risk for severe COVID-19

Coronavirus

People with HIV should be prioritised for COVID-19 vaccination due to higher risk, WHO recommends

Elimination of hepatitis C

Hepatitis C virtually eliminated in people with HIV in the Netherlands

HIV treatment

Efavirenz/emtricitabine/tenofovir disoproxil fumarate

HIV treatment

Efavirenz

Hepatitis C treatment

Liver transplant outcomes improve in people with HIV and hepatitis C

Liver disease

HIV treatment choice affects improvement in liver after hepatitis C cure

Weight gain & lipodystrophy

Weight gain after changing treatment more likely when switching from efavirenz or old-style tenofovir

HIV treatment

Tenofovir alafenamide

HIV treatment

Tenofovir disoproxil fumarate

HIV treatment

Descovy

HIV treatment

Tenofovir disoproxil fumarate

Vaccinations & immunisations

HIV status does not affect immune responses to Oxford/AstraZeneca vaccine, two studies show

Coronavirus

Fewer COVID-19 infections in people with HIV in San Francisco, but weaker antibody responses after infection

Hepatitis C symptoms & diagnosis

Hepatitis C testing in gay and bisexual men with HIV below target, US study finds

Coronavirus

COVID-19 and coronavirus in people living with HIV